| Inherited causes of clonal haematopoiesis in 97,691 whole genomes AG Bick, JS Weinstock, SK Nandakumar, CP Fulco, EL Bao, SM Zekavat, ... Nature 586 (7831), 763-768, 2020 | 498 | 2020 |
| Systematic functional dissection of common genetic variation affecting red blood cell traits JC Ulirsch, SK Nandakumar, L Wang, FC Giani, X Zhang, P Rogov, ... Cell 165 (6), 1530-1545, 2016 | 348 | 2016 |
| Advances in understanding erythropoiesis: evolving perspectives SK Nandakumar, JC Ulirsch, VG Sankaran British journal of haematology 173 (2), 206-218, 2016 | 190 | 2016 |
| Transcriptional states and chromatin accessibility underlying human erythropoiesis LS Ludwig, CA Lareau, EL Bao, SK Nandakumar, C Muus, JC Ulirsch, ... Cell reports 27 (11), 3228-3240. e7, 2019 | 154 | 2019 |
| Inherited myeloproliferative neoplasm risk affects haematopoietic stem cells EL Bao, SK Nandakumar, X Liao, AG Bick, J Karjalainen, M Tabaka, ... Nature 586 (7831), 769-775, 2020 | 118 | 2020 |
| Low-level GATA2 overexpression promotes myeloid progenitor self-renewal and blocks lymphoid differentiation in mice SK Nandakumar, K Johnson, SL Throm, TI Pestina, G Neale, DA Persons Experimental hematology 43 (7), 565-577. e10, 2015 | 59 | 2015 |
| Nfix is a novel regulator of murine hematopoietic stem and progenitor cell survival P Holmfeldt, J Pardieck, AC Saulsberry, SK Nandakumar, D Finkelstein, ... Blood, The Journal of the American Society of Hematology 122 (17), 2987-2996, 2013 | 49 | 2013 |
| Comprehensive population-based genome sequencing provides insight into hematopoietic regulatory mechanisms MH Guo, SK Nandakumar, JC Ulirsch, SM Zekavat, JD Buenrostro, ... Proceedings of the National Academy of Sciences 114 (3), E327-E336, 2017 | 44 | 2017 |
| Infantile myelofibrosis and myeloproliferation with CDC42 dysfunction JM Verboon, D Mahmut, AR Kim, M Nakamura, NJ Abdulhay, ... Journal of clinical immunology 40, 554-566, 2020 | 32 | 2020 |
| A genetic disorder reveals a hematopoietic stem cell regulatory network co-opted in leukemia RA Voit, L Tao, F Yu, LD Cato, B Cohen, TJ Fleming, M Antoszewski, ... Nature Immunology 24 (1), 69-83, 2023 | 29 | 2023 |
| Common variants in signaling transcription-factor-binding sites drive phenotypic variability in red blood cell traits A Choudhuri, E Trompouki, BJ Abraham, LM Colli, KH Kock, W Mallard, ... Nature genetics 52 (12), 1333-1345, 2020 | 28 | 2020 |
| A unified model of human hemoglobin switching through single-cell genome editing Y Shen, JM Verboon, Y Zhang, N Liu, YJ Kim, S Marglous, ... Nature communications 12 (1), 4991, 2021 | 24 | 2021 |
| Inherited causes of clonal hematopoiesis of indeterminate potential in TOPMed whole genomes AG Bick, JS Weinstock, SK Nandakumar, CP Fulco, MJ Leventhal, EL Bao, ... BioRxiv, 782748, 2019 | 22 | 2019 |
| In the blood: connecting variant to function in human hematopoiesis SK Nandakumar, X Liao, VG Sankaran Trends in Genetics 36 (8), 563-576, 2020 | 18 | 2020 |
| Gene-centric functional dissection of human genetic variation uncovers regulators of hematopoiesis SK Nandakumar, SK McFarland, LM Mateyka, CA Lareau, JC Ulirsch, ... Elife 8, e44080, 2019 | 17 | 2019 |
| Shared and distinct genetic etiologies for different types of clonal hematopoiesis DW Brown, LD Cato, Y Zhao, SK Nandakumar, EL Bao, EJ Gardner, ... Nature communications 14 (1), 5536, 2023 | 13 | 2023 |
| A genetic disorder reveals a hematopoietic stem cell regulatory network co-opted in leukemia R Voit, L Tao, F Yu, B Cohen, L Cato, X Liao, C Fiorini, SK Nandakumar, ... Blood 138, 861, 2021 | 1 | 2021 |
| Genetic predisposition to myeloproliferative neoplasms implicates hematopoietic stem cell biology EL Bao, SK Nandakumar, X Liao, A Bick, J Karjalainen, M Tabaka, OI Gan, ... bioRxiv, 790626, 2019 | 1 | 2019 |
| 3020–SPLICING OF A MASTER ERYTHROID TRANSCRIPTION FACTOR GOVERNS THERAPEUTIC TARGETING OF ANEMIA IN MDS S Aluri, T Ling, E Fraint, S Chakraborty, K Zhang, A Ahsan, G Poigaialwar, ... Experimental Hematology 137, 104342, 2024 | | 2024 |
| GDF11/SMAD Regulated Splicing of GATA1 Is Associated with Response to Luspatercept in Lower-Risk Myelodysplastic Syndromes (LR-MDS) S Aluri, E Fraint, S Chakraborty, A Ahsan, G Poigailwar, R Zhao, ... Blood 142, 318, 2023 | | 2023 |
